Recombinant Human IL-18 (without BSA)

1. Guia S et al. A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood 111, 5008-16 (2008)(PMID:18319400)

1. Takei S et al. Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis. Arthritis Res Ther. 13, R52 (2011)(PMID:21435242)

1. Reichwald K et al. TL1A induces TCR independent IL-6 and TNF-α production and growth of PLZF? leukocytes. PLoS One 9, e85793 (2014)(PMID:24416448)

1. Reichwald K et al. TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells. PLoS One 9, e105627 (2014)(PMID:25148371)

1. Iijima R et al. Interleukin-18 induces retinal pigment epithelium degeneration in mice. Invest Ophthalmol Vis Sci. 55, 6673-8 (2014)(PMID:25237159)

1. Guerville F et al. TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance. Oncoimmunology 4, e1003011 (2015)(PMID:26155394)

1. Molgora M et al. IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity. Nature 551, 110-114 (2017)(PMID:29072292)

1. Abe Y et al. Role of IL-18 on the activation of Vδ₂⁺ T cells - For the development of novel cancer immunotherapy - Ann. Cancer Res. Ther. 26, 71-76 (2018)

1. Tanaka Y et al. Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro. PLoS One. 14, e0212455 (2019) (PMID:30840664)

Function

1. Ambegaonkar AA et al. The Differentiation in vitro of Human Tonsil B Cells With the Phenotypic and Functional Characteristics of T-bet+ Atypical Memory B Cells in Malaria. Front Immunol. 10, 852 (2019)(PMID:31068937)
2. Stiglund N et al. Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease. Front Immunol. 10, 1255 (2019)(PMID:31214196)